Immunodulator Effects of Interferon Therapy on Incidence of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

被引：0
|
作者：
Kutala, Blaise [1 ,2 ]
Boyer, Nathalie [3 ]
Marchand, Corinne Castelnau [1 ]
Guigui, Nathalie Giuily [4 ]
Sitruk, Veronique [1 ]
Asselah, Tarik [5 ]
Marcellin, Patrick [6 ,7 ]
机构：
[1] Beaujon Hosp, AP HP, Hepatol, Clichy, France
[2] Univ Paris, Inserm 1149, Paris, France
[3] AP HP Beaujon, Hepatogastroenterol, Clichy, France
[4] Beaujon Hosp, Clichy, France
[5] Hop Beaujon, Dept Hepatol, Clichy, France
[6] Hop Beaujon, AP HP, Serv Hepatol, Clichy, France
[7] Univ Paris Diderot, INSERM, Paris, France
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
686
引用
收藏
页码：407A / 408A
页数：2
相关论文
共 50 条
  • [31] The effectiveness of interferon therapy on occurrence of hepatocellular carcinoma in chronic hepatitis C
    Horiike, N
    Fujisawa, T
    Michitaka, K
    Tada, K
    Masumoto, T
    Iuchi, H
    Kojima, N
    Onji, M
    ONCOLOGY REPORTS, 1998, 5 (05) : 1171 - 1174
  • [32] INCIDENCE OF HEPATOCELLULAR CARCINOMA AFTER ACHIEVING SUSTAINED VIROLOGICAL RESPONSE TO INTERFERON THERAPY FOR CHRONIC HEPATITIS C
    Watanabe, Hisayoshi
    Saito, Takafumi
    Ishii, Rika
    Sato, Chikako
    Haga, Hiroaki
    Sanja, Mai
    Okumoto, Kazuo
    Nishise, Yuko
    Ito, Junitsu
    Saito, Koji
    Kawata, Sumio
    HEPATOLOGY, 2010, 52 (04) : 1164A - 1164A
  • [33] Alcohol consumption increases the incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis but not in patients with hepatitis C cirrhosis
    Guan, Xin
    Xing, Fei
    Li, Yan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (09) : 1218 - 1221
  • [34] Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
    Lin, Shi-Ming
    Yu, Ming-Lung
    Lee, Chuan-Mo
    Chien, Rong-Nan
    Sheen, I-Shyan
    Chu, Chia-Ming
    Liaw, Yun-Fan
    JOURNAL OF HEPATOLOGY, 2007, 46 (01) : 45 - 52
  • [35] Interferon therapy reduces cirrhosis and hepatocellular carcinoma in HBeAg positive chronic hepatitis B
    Lin, S. M.
    Yu, M. L.
    Lee, C. M.
    Chien, R. N.
    Sheen, I. S.
    Chu, C. M.
    Liaw, Y. F.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S23 - S23
  • [36] Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy
    Shim, Jae-Jun
    Oh, Chi Hyuck
    Kim, Jung Wook
    Lee, Chang Kyun
    Kim, Byung-Ho
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (09) : 1029 - 1036
  • [37] Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
    Moon, Chansoo
    Jung, Kyu Sik
    Kim, Do Young
    Baatarkhuu, Oidov
    Park, Jun Yong
    Kim, Beom Kyung
    Kim, Seung Up
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (02) : 573 - 581
  • [38] Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
    Chansoo Moon
    Kyu Sik Jung
    Do Young Kim
    Oidov Baatarkhuu
    Jun Yong Park
    Beom Kyung Kim
    Seung Up Kim
    Sang Hoon Ahn
    Kwang-Hyub Han
    Digestive Diseases and Sciences, 2015, 60 : 573 - 581
  • [39] Hepatocellular Carcinoma after Sustained Viral Response to Interferon and Ribavirin Therapy in Cirrhosis Secondary to Chronic Hepatitis C
    Khokhar, Nasir
    Niazi, Tariq Khan
    Qureshi, Muhammad Omar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2013, 23 (10): : 699 - 702
  • [40] Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
    Nishiguchi, S
    Shiomi, S
    Nakatani, S
    Takeda, T
    Fukuda, K
    Tamori, A
    Habu, D
    Tanaka, T
    LANCET, 2001, 357 (9251): : 196 - 197
12345